Further, there was no significant difference in the rates of index progression beyond transplant criteria versus new disease leading to progression beyond transplant criteria, suggesting new disease was not the primary contributing factor to HCC progression risk in patients with albumin < 3.4 g/dL. Here, ALB is linked to hepatocellular carcinoma.